Conclusion Overall, the results of this real-world study support the concerns regarding GADRs if using semaglutide or liraglutide for overweight or obesity
If gastrointestinal side effects feel severe, arent improving, or are making it hard to stay hydrated, reach out to your healthcare provider
Food and nutrition insecurity and diabetes
10.1007/s00299-015-1912-8 Plant Cell Rep
Compared to bupropion-naltrexone, GLP-1 agonists were associated with a: 9.09 times higher risk of pancreatitis, or inflammation of the pancreas, which can cause severe abdominal pain and, in some cases, require hospitalization and surgery
Neglected analytes in the 24-h urine: ammonium and sulfate